PDT Partners, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 193 filers reported holding SEATTLE GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$9,100,000
+15.2%
46,5000.0%0.60%
+11.7%
Q2 2020$7,901,000
+2196.8%
46,500
+1444.9%
0.54%
+2461.9%
Q4 2019$344,000
-97.2%
3,010
-98.4%
0.02%
-95.4%
Q2 2018$12,119,000
+20.6%
182,546
-4.9%
0.46%
+35.7%
Q1 2018$10,045,000
-22.6%
191,912
-20.8%
0.34%
-9.8%
Q4 2017$12,970,000
-13.9%
242,423
-12.5%
0.38%
-24.5%
Q3 2017$15,072,000
+75.2%
277,003
+66.6%
0.50%
+43.9%
Q2 2017$8,602,000
+1.5%
166,246
+23.3%
0.35%
-22.1%
Q1 2017$8,476,000
+66.4%
134,846
+39.7%
0.44%
+32.9%
Q4 2016$5,095,000
-33.0%
96,546
-31.4%
0.33%
-24.9%
Q3 2016$7,599,000
+19.9%
140,700
-10.3%
0.44%
-11.4%
Q2 2016$6,336,000
-5.2%
156,800
-17.7%
0.50%
+19.8%
Q1 2016$6,685,000
+25.4%
190,500
+60.4%
0.42%
-42.7%
Q4 2015$5,332,000
+204.5%
118,800
+161.7%
0.73%
+1774.4%
Q3 2015$1,751,000
-52.4%
45,400
-60.4%
0.04%
-89.3%
Q4 2014$3,681,000
+66.7%
114,562
+92.9%
0.36%
+529.3%
Q3 2014$2,208,000
-40.3%
59,378
-38.6%
0.06%
-41.4%
Q2 2014$3,697,000
+26.7%
96,654
+51.0%
0.10%
+41.4%
Q1 2014$2,917,000
+12.7%
64,023
-1.4%
0.07%
-77.5%
Q4 2013$2,589,000
-20.6%
64,909
-12.8%
0.31%
+253.4%
Q3 2013$3,261,000
+3.4%
74,409
-25.7%
0.09%
+8.6%
Q2 2013$3,153,000100,2100.08%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders